Who we are.

Ryan was appointed CEO of Inizio in September 2025, following a four-year tenure as COO, during which he provided strategic leadership across global divisions. In this role, he worked closely with executive management teams to establish and deliver long-term strategic growth plans. Before this, Ryan was COO at UDG Healthcare. He brings over 25 years of experience in the pharmaceutical industry, holding senior commercial leadership roles. Prior to joining UDG Healthcare, Ryan served as Regional Vice President, Region South, and Immunology and HCV Lead for AbbVie Western Europe and Canada. 

Mary-Kate McGarry is Chief Strategy & Innovation Officer at Inizio, where she leads corporate strategy, innovation, global marketing and brand. She joined in 2021 with the Advisory leadership team, driving strategic initiatives following the UDG Healthcare and Huntsworth merger. Mary-Kate spearheaded Inizio’s integrated corporate strategy before assuming her current role, overseeing strategy across the business. She also leads the Group’s commercial innovation agenda - advancing platform development, use-case innovation, investment prioritization and colleague enablement - while shaping global brand positioning to fuel long-term growth. Previously, Mary-Kate spent her career in strategic consulting at EY and Accenture, specializing in large-scale transformation, organizational change, and multi-stakeholder strategy across healthcare, financial services, government, and utilities. 

Gavin McShera is Chief Information Officer at Inizio, where he provides strategic technology leadership across both our corporate functions and global business divisions. In this role, he is responsible for ensuring that technology solutions not only support day-to-day operations but also enable long-term business growth and innovation. Gavin also oversees Inizio’s global cybersecurity strategy - safeguarding critical data, protecting client and employee information, and building a culture of security awareness. He has 30 years of experience across healthcare, finance, professional services, aircraft leasing, retail, public sector, and technology. Before joining Inizio, Gavin was Group CIO at Applegreen PLC, held roles at Microsoft, and worked as an independent consultant. 

Ben was appointed Chief Financial Officer of Inizio following the acquisition of UDG Healthcare, having previously been CFO of Huntsworth Plc. Ben joined Huntsworth Plc in September 2016, stepping up to the Board in 2019. Before joining the team, he worked at ITE Plc, and International Exhibitions Organizer, as Group Financial Controller. Prior to that, Ben worked at Royal Bank of Scotland in banking roles, after training and qualifying with Deloitte in London. In his time at Inizio, Ben has overseen the transformation of the central functions to support the broader integration of the Group and to provide a platform for ongoing growth. 

Grainne became part of the Inizio team after joining UDG Healthcare in June 2018 as the UDG Head of Finance, with responsibility for Group Finance, Ashfield Finance Functions, Global Procurement & Real Estate, and Finance Transformation. Since joining Inizio, Grainne has led the Finance Transformation projects across the group, partnering with IT to move all businesses to a common financial ERP system, and establishing Shared Services for 30+ Ashfield agencies. Prior to UDG, she worked as General Manager, Ireland, and Vice President, Finance with Alexion, a rare disease US biotech company, leading their expansion in Ireland and a €500 million investment in biologics and packaging facilities in Ireland. Grainne previously spent ten years working with Elan Pharmaceuticals in the United States and Ireland in various corporate, strategic and group finance roles.   

Stephanie is the Global Chief People & Culture Officer of Inizio. She joined Inizio in 2022 and leads Inizio's talent strategy and People & Culture team, focusing on transforming the People & Culture organization to deliver a best-in-class experience for our people and differentiate Inizio in the market as a global employer of choice. With over 25 years of international experience as a strategy and management consultant, corporate leader, Chief Human Resources Officer and Board member, Stephanie brings a wealth of cross-industry knowledge and expertise including multi-cultural leadership experience gained working with Fortune 100 clients and leading global teams while living in London, Paris, Prague, Amsterdam and the US. 

Neil is an experienced Executive Director. He was the former CFO & COO of Huntsworth prior to the merger with UDG which formed Inizio. Before joining Huntsworth, Neil was CFO for several UK-listed public companies, having originally qualified as an accountant with PWC in the early 90’s. Before transitioning to an Advisor, Neil served as Corporate Development Director at Inizio where he was the head of M&A, leading on the Nucleus and Research Partnership transactions. He also lead property focusing on delivering the optimal property solution (space and environments) for employees, and served as the executive sponsor for both Sustainability and Inclusion & Impact - helping to shape strategy and deliver a best-in-class positioning for the company. He is also the Chairman of Accordience, Inizio’s non-healthcare PR agency Group. 

Colin is Inizio’s Chief Commercial Officer and is responsible for our Commercial Activities and Business Development, with a particular emphasis on the support of our Large Enterprise Accounts and the infrastructure that supports our Global Sales Team. Prior to his current role, he was President of Inizio Advisory from September 2019, where he oversaw Inizio’s Consulting and Research Businesses. Before Inizio, Colin spent 20 years at ICON, where he held several leadership positions, including President of ICON Functional Services. Colin is a seasoned leader in the pharma industry, bringing 30 years of experience across both clinical development and commercialization. He has a strong track record of driving business growth, both organically and through M&A, and improving margins through process optimization. 

Joining Medistrava in 2015, Elaine helped double the size of the organization through organic growth and acquisition to create a fully integrated medical, health economics and market access platform. Now, she joins us as President of Inizio Medical. As a trained neuropsychologist, Elaine has enjoyed a career in research and clinical practice before joining the industry, combining her background in science and behavior to drive evidence-based strategies that apply to real-world healthcare challenges.

Reid Connolly leads Inizio Evoke, a global health marketing, communications, and transformation platform dedicated to making health more human™. Since founding Evoke in 2006, Reid has been instrumental in evolving the agency into one of the most progressive, client-centric, and people-first agencies in the industry, embracing its digital and data-driven roots to create a uniquely integrated platform. Reid has also been recognized by PRWeek as one of the industry’s top voices, with honors on both the Health Influencer 50 and Health Influencer 30 lists. Prior to founding Evoke, Reid held senior leadership roles at Digitas Health, imc2, and Saatchi & Saatchi Healthcare, where he honed his expertise in integrated healthcare marketing. He has partnered with leading pharmaceutical and biotech companies, including AstraZeneca, Amgen, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Novartis, and Pfizer.

Joining Ashfield in 2005 as a Regional Account Director in the UK, Greg Flynn has since worked with our teams across the UK, Japan and the US. He established and ran our joint venture in Japan before moving to the US in 2017 to lead Engage. Greg was previously the President of Engage from 2019 - 2025.